COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

Abroad (travel likely)RecruitingPHASE2

Conditions

COVID 19 · Influenza · Rheumatoid Arthritis (RA) · Systemic Lupus Erthematosus · Inflammatory Bowel Disease · Solid Organ Transplant Recipients · Immunocompromised Host · People Living With HIV

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Maisonneuve -Rosemont Installation, Montreal, Quebec, Canada
Contact: Study coordinator (Lynne Senécal, MD) · lynne.senecal.med@ssss.gouv.qc.ca · 5142523400
Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada
Contact: Study coordinator (Heloise Cardinal, MD PhD) · heloise.cardinal.med@ssss.gouv.qc.ca · 514-890-8000
Research Institute of McGill University Health Centre, Montreal, Quebec, Canada
Contact: Study coordinator (Ruth Sapir-Pichhadze, B.Med.Sc., MD, MSc, PhD, FRCPC) · ruth.sapir-pichhadze.med@ssss.gouv.qc.ca · 5149341934

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

COMMUNITY - the COVID-19 Immunity Study

COVID 19 · Respiratory Synctial Virus · Influenza Virus

Abroad (travel likely)Recruiting

Stockholm, Sweden · Stockholm, Sweden

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

SARS-CoV-2 · Influenza, Human · Respiratory Syncytial Virus Infections

Abroad (travel likely)RecruitingPHASE1, PHASE2

Alcalá de Henares, Spain · Fuenlabrada, Spain

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

Influenza, Human+COVID-19

Abroad (travel likely)RecruitingPHASE1

Anniston, United States · Little Rock, United States

Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination

Influenza · COVID-19

Abroad (travel likely)Recruiting

Bethesda, United States